Worth reading
86Important
Scored from 3 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
Fiscal year ending March 2025 · Full yearNet Sales—→11,390million
—
Operating profit—→190million
—
Ordinary income—→290million
—
Profit attributable to owners of the parent—→210million
—
The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Reason for the revision
2025年3月期後半以降の難燃剤市況改善を前提とし、需要が底堅いヨウ素化合物と海外向けファインケミカル製品の拡販に取り組む
Details and amount of extraordinary loss
減損損失38百万円、固定資産除却損2百万円、投資有価証券売却損3百万円、特別損失合計44百万円
Previous-period results売上高9,686百万円、営業損失106百万円、経常損失11百万円、親会社株主に帰属する当期純利益76百万円、1株当たり当期純利益9円52銭
Dividend forecast revision期末配当は当初予定通り7.5円、通期15.0円
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥11,390 million（17.6%） |
| Operating profit | Not disclosed → ¥190 million |
| Ordinary income | Not disclosed → ¥290 million |
| Profit attributable to owners of the parent | Not disclosed → ¥210 million（176.3%） |
| Fiscal Period Covered | Fiscal year ending March 2025 |
| Period Covered | Full year |
| Previous-period results | 売上高9,686百万円、営業損失106百万円、経常損失11百万円、親会社株主に帰属する当期純利益76百万円、1株当たり当期純利益9円52銭 |
| Reason for the revision | 2025年3月期後半以降の難燃剤市況改善を前提とし、需要が底堅いヨウ素化合物と海外向けファインケミカル製品の拡販に取り組む |
| Details and amount of extraordinary loss | 減損損失38百万円、固定資産除却損2百万円、投資有価証券売却損3百万円、特別損失合計44百万円 |
| Dividend forecast revision | 期末配当は当初予定通り7.5円、通期15.0円 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
Net income per sharePublication date of previous forecast
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.2024年3月期は、難燃剤事業で国内外の市場環境悪化と需要減少が続き、販売数量・単価が下落したこと、ファインケミカル事業で電子材料製品市場の低迷と一部医薬関連製品の需要減少があったことが業績悪化の理由とされている。2025年3月期は、後半以降の難燃剤市況改善、ヨウ素化合物の底堅い需要、海外向けファインケミカル製品の拡販を前提としている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.